ArticleJournal of hepatocellular carcinoma2026
"WBC-HBP Dissociation" Unveils Occult Xanthogranulomatous Inflammation Mimicking Hepatocellular Carcinoma in Diabetic Patients.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The reliance on LI-RADS 5 imaging criteria for the non-invasive diagnosis of hepatocellular carcinoma (HCC) can be precarious in the setting of advanced liver fibrosis, where benign inflammatory mimics may exhibit deceptive vascular kinetics. Hepatic xanthogranulomatous inflammation (XGI) represents a rare but significant diagnostic pitfall, as it can strictly simulate the arterial phase hyperenhancement and subsequent washout characteristic of malignancy. This diagnostic ambiguity is exacerbated in diabetic patients by"diabetic immunoparesis"which masks localized infection through a deceptive absence of systemic leukocytosis. This study highlights a novel diagnostic signature, termed "WBC-HBP Dissociation"utilizing Heparin-Binding Protein (HBP) to unveil occult neutrophil activation otherwise obscured by normocytosis. Case Presentation: A 50-year-old male with chronic hepatitis B and biopsy-confirmed advanced fibrosis (LSM: 11.6 kPa) presented with a solitary, hypervascular liver mass. Despite uncontrolled Type 2 Diabetes (HbA1c: 12.00%) and a broad panel of negative tumor markers (AFP, PIVKA-II, CEA, CA19-9), both CEUS and MRI yielded a definitive LI-RADS 5 classification with suspected local invasion. Notably, while the white blood cell (WBC) count remained within the normal range (5.83× 10^9/L), a marked elevation in HBP (16.7ng/mL; Ref: <11.4ng/mL) suggested a localized inflammatory response. Guided by the radiological mandate for malignancy, the patient underwent an anatomical hepatectomy. Postoperative histopathology revealed XGI characterized by dense infiltration of lipid-laden foamy histiocytes, with immunohistochemistry (CD68+, SMA+, ALK-, IgG4-) effectively excluding neoplasia and IgG4-related disease. Conclusion: XGI can authentically mimic the hemodynamic signature of HCC, a challenge compounded by the "relative washout" effect of background fibrosis. The "WBC-HBP Dissociation" identified here serves as a critical serological red flag for occult inflammation in patients with metabolic comorbidities. Integrating HBP assessment into the diagnostic algorithm for LI-RADS 5 masses-especially when tumor markers are negative-may justify advanced metabolic imaging or biopsy, potentially sparing high-risk patients from unnecessary and morbid major hepatic resections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.